LAUER REGAN J
SEC insider (Form 3/4/5 filer). CIK 0001200637. Chief Accounting Officer at ImmunityBio, Inc. (IBRX). 10 reported Form 4/5 transactions since Sep 2024; latest on Feb 22, 2026. Located in SAN DIEGO, CA.
Companies LAUER REGAN J has filed insider reports for
- ImmunityBio, Inc. (IBRX): Officer, Chief Accounting Officer
LAUER REGAN J
CIK: 0001200637
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ImmunityBio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Feb 22, 2026IBRX
ImmunityBio, Inc.
ExerciseDirect4.1K shares- - Feb 22, 2026IBRX
ImmunityBio, Inc.
Tax PaymentDirect1.7K shares at avg. $8.70$15K - Feb 10, 2026IBRX
ImmunityBio, Inc.
ExerciseDirect5.5K shares- - Feb 10, 2026IBRX
ImmunityBio, Inc.
Tax PaymentDirect2.3K shares at avg. $6.93$16K - Feb 22, 2025IBRX
ImmunityBio, Inc.
ExerciseDirect4.1K shares- - Feb 22, 2025IBRX
ImmunityBio, Inc.
Tax PaymentDirect1.7K shares at avg. $3.42$6K - Feb 10, 2025IBRX
ImmunityBio, Inc.
AwardDirectRestricted Stock Units
16.4K shares- - Feb 10, 2025IBRX
ImmunityBio, Inc.
AwardDirectStock Option (right to buy)
56.3K shares- - Dec 15, 2024IBRX
ImmunityBio, Inc.
ExerciseDirect21K shares- - Dec 15, 2024IBRX
ImmunityBio, Inc.
Tax PaymentDirect7.5K shares at avg. $2.87$22K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 22, 2026 | IBRX ImmunityBio, Inc. | Exercise | 4,065 | - | $0 | Direct |
| Feb 22, 2026 | IBRX ImmunityBio, Inc. | Tax Payment | 1,673 | $8.70 | $14,555 | Direct |
| Feb 10, 2026 | IBRX ImmunityBio, Inc. | Exercise | 5,482 | - | $0 | Direct |
| Feb 10, 2026 | IBRX ImmunityBio, Inc. | Tax Payment | 2,257 | $6.93 | $15,641 | Direct |
| Feb 22, 2025 | IBRX ImmunityBio, Inc. | Exercise | 4,065 | - | - | Direct |
| Feb 22, 2025 | IBRX ImmunityBio, Inc. | Tax Payment | 1,669 | $3.42 | $5,708 | Direct |
| Feb 10, 2025 | IBRX ImmunityBio, Inc. | Award Restricted Stock Units | 16,447 | - | - | Direct |
| Feb 10, 2025 | IBRX ImmunityBio, Inc. | Award Stock Option (right to buy) | 56,250 | - | - | Direct |
| Dec 15, 2024 | IBRX ImmunityBio, Inc. | Exercise | 21,031 | - | $0 | Direct |
| Dec 15, 2024 | IBRX ImmunityBio, Inc. | Tax Payment | 7,503 | $2.87 | $21,534 | Direct |
1-10 of 10 transactions